• $154.9M
    Market Cap
  • N/A
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$5.51
$6.30
$6.02
1-Year Range
$2.71
$9.20
$6.02
Latest Close$6.02
Change
-$0.40 (-6.64%)
Volume91,501
Market Cap$154.9M
Shares Outstanding29.8M
P/E (TTM)-78.43
Diluted EPS (TTM)-$0.07
Enterprise Value$149.6M

Information as of 06/03/2026

Company Profile

TURN THERAPEUTICS INC
https://turntherapeutics.com
$154.9M
Market Cap
-$1.9M
Net Income
Sector: Healthcare
Industry: Biotechnology
250 N Westlake Blvd, Westlake Village, CA, United States, 91362
818 546 4011

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Key Executives

  • Bradley E. Burnam
  • Zuraiz Chaudhary
  • Mohammed Zubair
  • Neilesh Shailesh Ghodadra
  • Stephen Hahn FASTRO

Current Ownership Distribution

  • Other29.2M (98.15%)
  • Institutions462,310 (1.55%)
  • Mutual Funds88,680 (0.30%)
  • Insiders0 (0.00%)